Assay Detail
ADMET
CHEMBL4358413
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against HUVEC assessed as reduction in cell viability
2
Total Activities
2
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | ADMET |
| Organism | Homo sapiens |
| Cell Type | HUVEC |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Design, Synthesis, and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel PI3K/mTOR Dual Inhibitors.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 2 | 4.63 | 4.81 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL4440406 | — | — | 1 | 4.81 |
| CHEMBL3218576 | COPANLISIB | 4.0 | 1 | 4.45 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL4440406 | — | IC50 | = | 15530.0 | nM | 4.81 |
| CHEMBL3218576 | COPANLISIB | IC50 | = | 35420.0 | nM | 4.45 |